MY7500028A - Bromo-ergocryptine - Google Patents

Bromo-ergocryptine

Info

Publication number
MY7500028A
MY7500028A MY28/75A MY7500028A MY7500028A MY 7500028 A MY7500028 A MY 7500028A MY 28/75 A MY28/75 A MY 28/75A MY 7500028 A MY7500028 A MY 7500028A MY 7500028 A MY7500028 A MY 7500028A
Authority
MY
Malaysia
Prior art keywords
ergocryptine
bromo
Prior art date
Application number
MY28/75A
Other languages
English (en)
Inventor
Edward Fluckiger
Franz Troxler
Albert Hofmann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY7500028A publication Critical patent/MY7500028A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
MY28/75A 1968-05-31 1975-12-30 Bromo-ergocryptine MY7500028A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH816868A CH507249A (de) 1968-05-31 1968-05-31 Verfahren zur Herstellung von 2-Brom-a-ergokryptin

Publications (1)

Publication Number Publication Date
MY7500028A true MY7500028A (en) 1975-12-31

Family

ID=4336202

Family Applications (1)

Application Number Title Priority Date Filing Date
MY28/75A MY7500028A (en) 1968-05-31 1975-12-30 Bromo-ergocryptine

Country Status (19)

Country Link
US (2) US3752814A (xx)
AT (1) AT301765B (xx)
BE (1) BE733799A (xx)
BR (1) BR6909341D0 (xx)
CA (1) CA953720A (xx)
CH (1) CH507249A (xx)
CS (1) CS163736B2 (xx)
CY (1) CY780A (xx)
DE (1) DE1926045C3 (xx)
DK (1) DK124884B (xx)
FI (1) FI49035C (xx)
FR (1) FR2009737A1 (xx)
GB (1) GB1257841A (xx)
IT (1) IT7827515A0 (xx)
MY (1) MY7500028A (xx)
NL (1) NL151374B (xx)
PL (1) PL80058B1 (xx)
SE (1) SE341854B (xx)
YU (1) YU33970B (xx)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
CH619468A5 (xx) * 1976-01-12 1980-09-30 Sandoz Ag
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
YU39786B (en) * 1976-12-23 1985-04-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-alfa-ergocriptine
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
YU39849B (en) * 1978-09-26 1985-04-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-ergolene and 2-bromo-ergoline compounds
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
JPS606815A (ja) * 1983-06-24 1985-01-14 Mitsutoyo Mfg Co Ltd 微動送り装置
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
IE62715B1 (en) * 1989-03-10 1995-02-22 Endorecherche Inc Combination therapy for treatment of estrogen sensitive diseases
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5817751A (en) * 1994-06-23 1998-10-06 Affymax Technologies N.V. Method for synthesis of diketopiperazine and diketomorpholine derivatives
US5792748A (en) * 1995-06-07 1998-08-11 The General Hospital Corporation Method for inhibiting neoplastic disease in mammals
JP2000509398A (ja) * 1996-05-01 2000-07-25 エルゴ・リサーチ・コーポレイション 神経内分泌リセット治療及び光動的治療を用いた固形腫瘍の成長阻害及び根絶
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
US5874589A (en) * 1997-07-18 1999-02-23 Glaxo Wellcome, Inc. Methods for synthesizing diverse collections of tetramic acids and derivatives thereof
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
CA2590533C (en) * 2004-11-23 2010-09-07 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US8283312B2 (en) * 2005-02-04 2012-10-09 The Research Foundation Of State University Of New York Compositions and methods for modulating body weight and treating obesity-related disorders
WO2006099877A1 (en) * 2005-03-24 2006-09-28 Atef Mohammed Mostafa Darwish Rectal and vaginal suppositories containing bioadhesive bromocriptine and poloxamer
US20080269233A1 (en) * 2005-08-04 2008-10-30 Mark David Andrews Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
RS20080371A (xx) * 2006-02-23 2009-07-15 Pfizer Limited, Piperidinoilpirolodini agonisti receptora melanokortina tipa 4
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008059335A1 (en) 2006-11-13 2008-05-22 Pfizer Products Inc. Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
EP2099755A2 (en) * 2006-11-20 2009-09-16 Glenmark Pharmaceuticals S.A. Acetylene derivatives as stearoyl coa desaturase inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
JP5328244B2 (ja) * 2008-07-07 2013-10-30 株式会社ニュージェン・ファーマ 筋萎縮性側索硬化症治療剤
MX2011001405A (es) * 2008-08-06 2011-03-21 Pfizer Ltd Compuestos de diazepina y diazocano como agonistas de mc4.
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
EP2930175A4 (en) 2012-12-10 2016-12-21 Kissei Pharmaceutical NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF
EP3445362B1 (en) * 2016-04-20 2021-09-22 VeroScience LLC Composition and method for treating metabolic disorders
CA3068575A1 (en) 2017-06-28 2019-01-03 Kyoto University Agent for preventing and/or treating alzheimer's disease
WO2019079623A1 (en) 2017-10-18 2019-04-25 Veroscience Llc ENHANCED BROMOCRIPTINE FORMULATIONS

Also Published As

Publication number Publication date
NL151374B (nl) 1976-11-15
FI49035B (xx) 1974-12-02
FR2009737A1 (xx) 1970-02-06
FI49035C (fi) 1975-03-10
PL80058B1 (xx) 1975-08-30
BR6909341D0 (pt) 1973-02-08
CH507249A (de) 1971-05-15
CY780A (en) 1975-03-01
CS163736B2 (xx) 1975-11-07
US3752888A (en) 1973-08-14
BE733799A (xx) 1969-12-01
CA953720A (en) 1974-08-27
DE1926045A1 (de) 1969-12-04
NL6907038A (xx) 1969-12-02
DK124884B (da) 1972-12-04
YU33970B (en) 1978-09-08
DE1926045C3 (de) 1978-09-21
DE1926045B2 (de) 1978-01-12
YU133669A (en) 1978-02-28
AT301765B (de) 1972-09-25
US3752814A (en) 1973-08-14
GB1257841A (xx) 1971-12-22
SE341854B (xx) 1972-01-17
IT7827515A0 (it) 1978-09-11

Similar Documents

Publication Publication Date Title
CY780A (en) Bromo-ergocryptine
YU176068A (en) Farmaceutska kapsula
MY7400300A (en) N-tritylimidazole
IL33473A0 (en) Diazepine-derivatives
IL32493A0 (en) Imidazolidino-quinazolines
YU169969A (en) Izmenjivac toplote
IE32701L (en) Pyridazones-herbicides
CY728A (en) Omega-cyanoalkylcarbamylbenzimidazoles
IL32959A (en) 4-cyano-4-phenyl-aminocyclohexanes
IL31738A0 (en) Dibenzocycloheptenes
IL32325A0 (en) 1-halogen-1-formylcarbonyl-phenylhydrazones
YU129169A (en) Elektricna pegla
IL31705A0 (en) Dibenzocycloheptenes
YU153769A (en) Elektricni postavni uredaj
MY7400045A (en) Hexahydroazepines
YU193169A (en) Cipela
YU204869A (en) Prigusivac torzionih oscilacija prstenastog klatna ispunjen viskoznom tecnoscu
YU125569A (en) Klizni zatvarac
IL32346A (en) 3-substituted-benzyl cyclopropane-carboxylates
IL32875A (en) Oxazinobenzodiazepines
IL31653A (en) 18-nor-13beta-ethyl-5alpha-androstan-3-ones
IL33043A (en) Aminobenzocycloalkylnitriles
IL35339A0 (en) Crossbar-distributor
IL32326A (en) Cyanoglyoxylate-phenylhydrazones
IL32920A (en) 2-halogeno-18-methyl-delta1-androstenes